Attributes | Values |
---|
rdf:type
| |
Description
| - This review provides a brief overview of the variety of carriers employed for targeted drug delivery used in cancer therapy summarizing advantages and disadvantages of each approach. Particularly, we aim our attention at polymeric nanocarriers, liposomes, micelles, polyethylene glycol, poly(lactic-co-glycolic acid), dendrimers, gold and magnetic nanoparticles, quantum dots, silica nanoparticles and carbon nanotubes. Further, we briefly focus on several anticancer agents (paclitaxel, docetaxel, camptothecin, doxorubicin, daunorubicin, cisplatin, curcumin and geldanamycin) and to the influence of their combination with nanoparticulate transporters to their properties such as cytotoxicity, short life time and/or solubility
- This review provides a brief overview of the variety of carriers employed for targeted drug delivery used in cancer therapy summarizing advantages and disadvantages of each approach. Particularly, we aim our attention at polymeric nanocarriers, liposomes, micelles, polyethylene glycol, poly(lactic-co-glycolic acid), dendrimers, gold and magnetic nanoparticles, quantum dots, silica nanoparticles and carbon nanotubes. Further, we briefly focus on several anticancer agents (paclitaxel, docetaxel, camptothecin, doxorubicin, daunorubicin, cisplatin, curcumin and geldanamycin) and to the influence of their combination with nanoparticulate transporters to their properties such as cytotoxicity, short life time and/or solubility (en)
|
Title
| - Nanocarriers for anticancer drugs - New trends in nanomedicine
- Nanocarriers for anticancer drugs - New trends in nanomedicine (en)
|
skos:prefLabel
| - Nanocarriers for anticancer drugs - New trends in nanomedicine
- Nanocarriers for anticancer drugs - New trends in nanomedicine (en)
|
skos:notation
| - RIV/00216305:26620/13:PU95529!RIV14-GA0-26620___
|
http://linked.open...avai/riv/aktivita
| |
http://linked.open...avai/riv/aktivity
| - I, P(ED1.1.00/02.0068), P(GAP102/11/1068)
|
http://linked.open...iv/cisloPeriodika
| |
http://linked.open...vai/riv/dodaniDat
| |
http://linked.open...aciTvurceVysledku
| |
http://linked.open.../riv/druhVysledku
| |
http://linked.open...iv/duvernostUdaju
| |
http://linked.open...titaPredkladatele
| |
http://linked.open...dnocenehoVysledku
| |
http://linked.open...ai/riv/idVysledku
| - RIV/00216305:26620/13:PU95529
|
http://linked.open...riv/jazykVysledku
| |
http://linked.open.../riv/klicovaSlova
| - Nanotechnologies, Nanoparticles, Gene Therapy, Anticancer drugs, Drug carriers, Cancer, Cytostatic, Targeted therapy. (en)
|
http://linked.open.../riv/klicoveSlovo
| |
http://linked.open...odStatuVydavatele
| |
http://linked.open...ontrolniKodProRIV
| |
http://linked.open...i/riv/nazevZdroje
| |
http://linked.open...in/vavai/riv/obor
| |
http://linked.open...ichTvurcuVysledku
| |
http://linked.open...cetTvurcuVysledku
| |
http://linked.open...vavai/riv/projekt
| |
http://linked.open...UplatneniVysledku
| |
http://linked.open...v/svazekPeriodika
| |
http://linked.open...iv/tvurceVysledku
| - Adam, Vojtěch
- Chomoucká, Jana
- Drbohlavová, Jana
- Hubálek, Jaromír
- Kizek, René
- Vaculovičová, Markéta
|
issn
| |
number of pages
| |
http://bibframe.org/vocab/doi
| - 10.2174/1389200211314050005
|
http://localhost/t...ganizacniJednotka
| |